Early vs Late Recurrence: How Multimodal AI Is Changing Breast Cancer Prognosis with George Sledge, Caris Life Sciences
George Sledge explains how multimodal AI is changing breast cancer prognosis by improving long-term recurrence prediction. Findings from the TAILORx trial show that combining molecular sequencing, digital pathology, and clinical data offers better insights than earlier…